Partnership proposal · prepared for Linda & Alan
Three live patient surfaces, a 50-state async Rx engine, surgeon-side RTM documentation, and a VA federal beachhead — AKS-clean by construction. Fixed fee. Day 0 is whenever we sign.
The science is done — 57% post-op pain reduction, 50%+ narcotic use cut, 800% faster wound healing, zero side-effect signal across millions of treatments. Growth is stuck at rep headcount. The patient internet goes untouched.
A $500 device that could be nearly free with HSA pre-tax dollars reads as a $500 sticker plus a physician-paperwork hurdle. Most patients defer. The problem is solvable — it just requires a 50-state async Rx engine that doesn't exist in the current model.
Post-surgical recovery (47,000 opioid deaths annually), chronic MSK pain (OA and tendinopathy patients who've failed NSAIDs and cortisone), and CMS-covered wound care (G0329 since 2004 — most eligible patients still don't know). None of these are reached by a rep.
tPEMF maps directly to Remote Therapeutic Monitoring: 98975 setup ($21.71), 98977 device supply 16–30 days ($40.08), 98980 treatment management first 20 min ($53.81) — roughly $115 per patient per protocol cycle under the surgeon's own NPI. Nobody is putting that math in front of surgeons.
RTM codes & documentation →“Used it on my hand for 15 minutes — in 4–5 hours all the inflammation was gone. Excited to get mine.”
Not a vendor arrangement. Equity-aligned, risk-sharing, with a compliance posture that holds under any healthcare attorney's review.
Take-title wholesale
Heal Without takes title to SofPulse devices at wholesale, sells direct-to-consumer across all three demand surfaces — post-surgical, chronic MSK, wound care. Commercial risk lands on the distribution side, not SofPulse's balance sheet.
Upside aligned to performance
Equity vests only as commercial milestones land — platform live, VA contract signed, units shipped. Dilution happens precisely when the company is worth more. Never before.
$5K / mo + $50 / unit — AKS-clean
The federal VA lines and clinical coordination require a separate, compliance-hardened fee structure. Every dollar is fixed, set in advance, FMV-justified — Anti-Kickback Personal Services safe harbor (42 CFR 1001.952(d)) by construction.
tPEMF maps directly to Remote Therapeutic Monitoring. The prescribing surgeon bills under their own NPI. Heal Without provides the documentation. Nobody is putting this math in front of surgeons today.
| CPT | Description | 2026 CMS rate | Frequency |
|---|---|---|---|
| 98975 | Initial device setup + patient education | $21.71 | One-time per episode |
| 98977 | Device supply (MSK) — 16–30 days | $40.08 | Per 30-day period |
| 98980 | Treatment management — first 20 min | $53.81 | Per 30-day period |
| Per-cycle total | ~$115 | per patient / 30-day cycle | |
Surgeon bills under their own NPI — revenue accrues to their practice, not SofPulse or SolvingHealth. Shown as a sales tailwind that drives re-prescribing.
During the 90-day global surgery period, the operating surgeon cannot separately bill RTM for Medicare patients (bundled into the surgical fee). RTM is available to: the PT / physiatrist / PCP as a co-managing provider, or the same surgeon for non-Medicare payers, or after the global period ends.
The SMS PROM engine (daily VAS via Twilio — 98%+ open rate, 45% reply rate, no app install) IS the qualifying patient-generated data layer RTM requires. Documentation flows the day the box ships.
New 2026 codes 98979 (treatment management 10–19 min, ~$26) and 98985 (device supply 2–15 days, ~$22) expand billing flexibility for shorter observation windows.
Conservative model at $500 device retail. Every fee is flat — no percentage-of-sale lines anywhere. Surgeon-side RTM revenue accrues to the prescribing practice, shown as a sales tailwind, not SofPulse revenue.
| Year · ramp | Units | SH fees | SofPulse net | RTM tailwind |
|---|---|---|---|---|
Year 1 Avg 100 / mo — VA pilot + early DTC | 1,200 | $120,000 | $478,800 | $138,720 |
Year 2 Avg 200 / mo — VA scale + DTC ramp | 2,400 | $180,000 | $1,017,600 | $277,440 |
Year 3 Avg 400 / mo — surgeon referral compounding | 4,800 | $300,000 | $2,095,200 | $554,880 |
| 3-yr cumulative | 8,400 | $600,000 | $3,591,600 | $971,040 |
The ask
The relationship is qualified, the architecture is documented, and every surface you just saw is already in production. The fixed-fee floor ($5,000/month + $50/unit) keeps the federal lines clean — then we paper the exclusive distribution rights and the milestone-vested equity that shares the upside we build together.
Confidential. Modeled at a $500 device retail — replace with SofPulse ASP for exact figures. RTM revenue accrues to the prescribing surgeon's practice, not SofPulse or SolvingHealth — shown as a sales tailwind, not booked revenue. RTM is subject to the 90-day global surgery period for Medicare patients; the PT / co-managing physician is the eligible billing provider during that window. Not indexed. Not for distribution.